Analyst consensus rating
Korsana Biosciences Analyst Rating: Strong Buy
Direct answer
Korsana Biosciences's consensus rating is Strong Buy.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $35.33.
Forecast evidence checked September 28, 2026.
Get free Korsana Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $30.83
- Average price target
- $35.33
- High price target
- $55.00
- Low price target
- $8.00
- Low target gap
- -74.1%
- Target upside
- +14.6%
- High target gap
- +78.4%
- Target range width
- 152.4%
- Consensus rating
- Strong Buy
- Analysts
- 3
- Evidence date
- September 28, 2026
- Valid through
- October 5, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Korsana Biosciences?
Korsana Biosciences has a verified Strong Buy consensus. The same dataset has an average price target of $35.33.
How far are Korsana Biosciences's low and high targets from the recorded price?
The low target implies -74.1%, while the high target implies +78.4%.
How many analysts are included in Korsana Biosciences's consensus?
The verified consensus includes 3 analysts.
How is Korsana Biosciences's target upside or downside calculated?
The average target of $35.33 is divided by the recorded price of $30.83, then one is subtracted to produce +14.6%. This does not guarantee a future return.
When was Korsana Biosciences's analyst forecast verified?
The data was verified on 2026-09-28. The dataset is valid through 2026-10-05.